课题基金 / 基金详情

ROLE OF ACCESSORY CELLS IN IMMUNE RESPONSES

ROLE OF ACCESSORY CELLS IN IMMUNE RESPONSES
辅助细胞在免疫反应中的作用
批准号:
3135940
负责人:
CAROL O COWING
金额:
$26.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1996-04-30

项目摘要

项目成果

CAROL O COWING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antigen-presenting cells (APCs) process foreign antigens into peptides that are bound by class II molecules of the Major Histocompatibility Complex and expressed on the plasma membrane as the ligand for clonal activation of CD4+ T lymphocytes. The function of APCs is critical in the initiation and regulation of immune responses. The long range goal of this research is to identify the class II+ cell types which perform this function in vivo. This will be accomplished using well- characterized class II transgenic mice and allogeneic bone marrow- reconstituted SCID mice that express a particular class II molecule or haplotype on different cell types. These animals will be immunized with soluble protein antigens that can be internalized via either non-specific mechanisms or receptor-mediated endocytosis, with particulate proteins requiring phagocytosis and with intracellular parasites. The working hypothesis is that foreign antigens must compete with self proteins for the peptide binding site on a class II molecule; and, therefore, a class II+ cell can be an effective APC only for those antigens that it can concentrate by receptor-mediated endocytosis or that reach high concentrations as a result of intracellular growth. Operationally this would mean that antigen-specific B cells are the requisite APCs for soluble protein antigens in vivo, while macrophages may be the principle APCs for particulate antigens and obligate intracellular parasites. A knowledge of which class II+ cell types function as APCs in vivo for the activation CD4+ T cells to different forms of antigen will aid in the design and delivery of new synthetic vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines
  • 批准号:
    7220527
  • 项目类别:
  • 资助金额:
    $29.36万
  • 财政年份:
    2007
  • 负责人:
    CAROL O COWING
  • 依托单位:
Topical adjuvants to enhance the efficacy of influenza vaccines
  • 批准号:
    8053319
  • 项目类别:
  • 资助金额:
    $61.42万
  • 财政年份:
    2007
  • 负责人:
    CAROL O COWING
  • 依托单位:
Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines
  • 批准号:
    7442275
  • 项目类别:
  • 资助金额:
    $29.36万
  • 财政年份:
    2007
  • 负责人:
    CAROL O COWING
  • 依托单位:
Topical adjuvants to enhance the efficacy of influenza vaccines
  • 批准号:
    7804448
  • 项目类别:
  • 资助金额:
    $67.36万
  • 财政年份:
    2007
  • 负责人:
    CAROL O COWING
  • 依托单位:
海外基金